원격 케어 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 지역별, 부문 예측(2025-2030년)

Telecare Market Size, Share & Trends Analysis Report By Type (Activity Monitoring, Remote Medication Management), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,641,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,094,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,998,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

원격 케어 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 원격 케어 시장 규모는 2025-2030년에 4.79%의 CAGR을 기록하며, 2030년에는 63억 4,000만 달러에 달할 것으로 추정되고 있습니다.

원격 진료는 주로 취약계층나 노약자에게 서비스를 제공하며, 응급상황이 발생했을 때 즉시 누군가와 연락하여 도움을 요청할 수 있습니다. 또한 전화에서 온라인 가상 방문에 이르기까지 새로운 기술의 발전이 진행됨에 따라 현대 의료 서비스의 양상이 형성되고 있습니다. 이처럼 기술의 발전은 시장 성장을 가속하는 데 중요한 역할을 하고 있습니다. 웨어러블 기기, 원격 모니터링 시스템, 원격의료 플랫폼과 같은 혁신은 실시간 건강 모니터링, 가상 진료, 원격 환자 관리를 가능하게 함으로써 의료 서비스 제공에 혁명을 일으키고 있습니다. 예를 들어 2023년 6월 Telecare는 전자 처방전을 위한 호주의 독립형 플랫폼인 RxPad를 발표했습니다.

임상의가 임상의를 위해 임상의가 설계한 이 혁신적인 솔루션은 기존의 종이 처방전을 대체하는 것을 목표로 하고 있으며, RxPad는 의료 서비스 제공에 혁명을 일으키고, 환자 경험을 개선하고, 의사에게 권한을 부여하여 모든 사람이 보다 효율적이고 즐거운 진료를 받을 수 있도록 돕습니다. 이 혁신적인 장비는 시장에서 가장 진보된 기능을 제공합니다. 또한 고령화 인구 증가는 시장 확대의 큰 요인으로 작용하고 있습니다. 고령화 인구가 증가함에 따라 의료 서비스, 특히 만성질환 관리 및 노인 케어에 대한 수요가 증가하고 있습니다. 원격 진료는 노인들에게 지속적인 모니터링과 지원을 제공함으로써 이러한 수요를 충족시킬 수 있는 실행 가능한 솔루션을 제공합니다. 이를 통해 노인 환자들은 적시에 치료를 받으면서도 독립적인 생활을 할 수 있습니다.

이러한 인구 통계학적 변화로 인해 고령자 특유의 니즈를 충족시키고 고령화 사회의 안전, 건강, 행복을 증진시키는 원격의료 솔루션 시장이 크게 형성되고 있습니다. 또한 만성질환의 유병률 증가와 개인화된 헬스케어 솔루션에 대한 수요 증가로 인해 원격의료 기술의 채택이 증가하고 있습니다. 당뇨병, 고혈압, 심장병과 같은 만성질환은 지속적인 모니터링과 관리가 필요하며, 원격 모니터링 솔루션을 통해 효과적으로 관리할 수 있습니다. 원격 진료는 예방적 질병 관리, 합병증 조기 발견, 적시 개입을 가능하게 하여 장기적으로 환자 결과 개선과 의료비 절감으로 이어집니다. 헬스케어 이해관계자들이 원격 모니터링 및 케어 관리 솔루션이 접근성, 비용 효율성, 환자 중심의 헬스케어 서비스를 제공하는 데 있으며, 원격 모니터링 및 케어 관리 솔루션의 혁신적 잠재력을 인식함에 따라 이 시장은 지속적으로 성장할 것으로 예측됩니다.

원격 진료 시장 보고서 하이라이트

• 원격 복약관리 분야가 2024년 50.97%의 최대 매출 점유율로 시장을 선도했습니다. 고령화, 만성질환의 유병률 증가, 노인용 원격 진료 앱 개발, 기술 발전 등 여러 요인이 영향을 미치고 있습니다.
• 활동 모니터링 분야는 기술 발전, 의료 서비스 접근성 및 결과 개선에 대한 수요 증가로 인해 예측 기간 중 높은 CAGR로 성장할 것으로 예측됩니다.
• 북미는 2024년 49.13%의 최대 매출 점유율로 원격의료 시장을 장악했는데, 이는 스마트폰과 인터넷의 높은 보급률, 신체 건강 유지에 대한 개인의 인식 증가, 원격의료 서비스 이용 등 여러 가지 요인에 기인합니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 원격 케어 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 보조 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회 분석
  • 시장이 해결해야 할 과제 분석
• 원격 케어 : 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTLE 분석
• 원격 케어 시장 : 의료 시스템 분야에서의 성과와 기회
• 원격 케어 시장에서 신규 기업과 기존 기업의 분석
• 국가별 규제 상황

제4장 원격 케어 시장 부문 분석, 유형별, 2018-2030년

• 정의와 범위
• 유형별 시장 점유율 분석, 2024년 및 2030년
• 부문 대시보드
• 세계의 원격 케어 시장(유형별, 2018-2030년)
• 액티비티 모니터링
• 원격 투약 관리

제5장 원격 케어 시장 부문 분석, 지역별, 2018-2030년

• 지역별 시장 점유율 분석, 2024년 및 2030년
• 지역별 시장 대시보드
• 지역별 시장 스냅숏
• 지역별 원격 케어 시장 점유율, 2024년 및 2030년
• 북미
  • 북미의 원격 케어 시장, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 원격 케어 시장, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 아시아태평양의 원격 케어 시장, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 라틴아메리카의 원격 케어 시장, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 원격 케어 시장, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제6장 경쟁 구도

• 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
• 기업 분류
• Company Position Analysis
• Company Evaluation Metrix
• 기업 개요
  • Teladoc Health, Inc.
  • Abbott Laboratories
  • Johnson and Johnson
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • NeoRehab
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck and Co., Inc.
  • Pfizer, Inc.
  • Sanofi
  • Samsung Electronics Co. Ltd
  • Qualcomm Technologies, Inc.
  • Orange
  • Google(Alphabet), Inc
  • Allscripts
  • Apple, Inc.
  • AT&T
  • Airstrip Technologies, Inc

KSA

영문 목차

영문목차

Telecare Market Growth & Trends:

The global telecare market size is estimated to reach USD 6.34 billion by 2030, registering a CAGR of 4.79% from 2025 to 2030, according to a new report by Grand View Research, Inc. Telecare provides services mainly to vulnerable and elderly individuals for immediate contact with someone for help in case of any emergency. In addition, the increasing development of new technology, from telephones to online virtual visits, has shaped the face of modern healthcare services. Thus, technological advancements have played a crucial role in driving the market growth. Innovations, such as wearable devices, remote monitoring systems, and telemedicine platforms, have revolutionized healthcare delivery by enabling real-time health monitoring, virtual consultations, and remote patient management. For instance, in June 2023, Telecare introduced RxPad, Australia's standalone platform for electronic prescriptions.

Designed by clinicians for clinicians, this innovative solution aims to replace traditional paper prescriptions. RxPad is poised to revolutionize healthcare delivery, improving patient experiences and empowering doctors, making consultations more efficient and enjoyable for everyone involved. This innovative device offers the most advanced features in the market. Moreover, the growing aging population is a significant factor propelling market expansion. With the growing aging population, the demand for healthcare services increases, particularly for chronic disease management and elderly care. Telecare offers a viable solution to meet these demands by providing continuous monitoring and support for older adults. It enables elderly patients to live independently while ensuring they receive timely medical attention.

This demographic shift is creating a substantial market for telecare solutions that cater to the specific needs of older individuals, promoting safety, health, and well-being in an aging society. Furthermore, the increasing prevalence of chronic diseases and rising demand for personalized healthcare solutions have propelled the adoption of telecare technologies. Chronic conditions, such as diabetes, hypertension, and heart disease, require continuous monitoring and management, which can be effectively facilitated through remote monitoring solutions. Telecare enables proactive disease management, early detection of complications, and timely interventions, leading to improved patient outcomes and reduced healthcare costs in the long run. The market is poised for continued growth as healthcare stakeholders recognize the transformative potential of remote monitoring and care management solutions in delivering accessible, cost-effective, and patient-centered healthcare services.

Telecare Market Report Highlights:

• The remote medication management segment led the market with the largest revenue share of 50.97% in 2024, attributed to several factors, including the aging population, increased prevalence of chronic diseases, development of elderly telecare apps and technological advancements.
• The activity monitoring segment is anticipated to grow at the significant CAGR over the forecast period, owing to technological advancements and the increasing demand for improved healthcare access and outcomes.
• North America dominated the telecare market with the largest revenue share of 49.13% in 2024, attributed to several factors such as the high penetration of smartphones and the internet, growing awareness among individuals to maintain physical health and the use of remote healthcare services.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Telecare Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Aging population and elderly care needs for telecare
    • 3.2.1.2. Technological improvements in AI and ML
    • 3.2.1.3. Advances in wearable health technology
    • 3.2.1.4. Growing shift to home healthcare services
    • 3.2.1.5. Increased focus on chronic disease management
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Privacy and security concerns over patient data
    • 3.2.2.2. Complexity of regulatory compliance
    • 3.2.2.3. Lack of standardization across platforms
    • 3.2.2.4. Limited insurance reimbursement for telecare services
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Leveraging ai, big data, and predictive analytics
    • 3.2.3.2. Collaborations with healthcare providers and insurers
    • 3.2.3.3. Increased focus on mental health and remote counseling
  • 3.2.4. Market challenges analysis
    • 3.2.4.1. Connectivity and infrastructure gaps in rural areas
    • 3.2.4.2. Resistance from healthcare providers and traditional systems
• 3.3. Telecare: Market Analysis Tools
  • 3.3.1. Industry analysis - Porter's
  • 3.3.2. PESTLE analysis
• 3.4. Telecare Market: Accomplishments and Opportunities Across the Health System Sectors
• 3.5. Analysis on Start-ups and Established Companies in Telecare Market
• 3.6. Regulatory Landscape, By Country
  • 3.6.1. Regulatory overview
  • 3.6.2. Health data privacy and security laws
  • 3.6.3. Telemedicine licensing and reimbursement policies
  • 3.6.4. Government initiatives and support
  • 3.6.5. Emerging trends in regulatory compliance
• 3.7. Value Chain Analysis
  • 3.7.1. Telecare value chain overview
  • 3.7.2. Key stakeholders and their roles
  • 3.7.3. Technology providers and platforms
  • 3.7.4. Service delivery and interoperability
  • 3.7.5. Distribution and supply chain management
  • 3.7.6. Revenue streams and business models
  • 3.7.7. Challenges in the value chain
• 3.8. Technology Landscape
  • 3.8.1. Technological advancements driving telecare
  • 3.8.2. Telecare software and applications
  • 3.8.3. Data analytics and artificial intelligence
  • 3.8.4. Wearable devices and IoT integration
  • 3.8.5. Telecommunication infrastructure
• 3.9. Case Study Analysis
• 3.10. Funding/Investment Trends Scenario
  • 3.10.1. Venture capital (VC) deal activity
  • 3.10.2. Top 10 digital health VC deals in 2024
  • 3.10.3. Annual equity funding & deals
  • 3.10.4. Quarterly equity funding & deals
  • 3.10.5. Quarter funding & deals by global region
  • 3.10.6. Percent of quarterly deals by global region
  • 3.10.7. Percent of quarterly deals by investor group
  • 3.10.8. Annual average & median deal size
  • 3.10.9. Annual median deal size by global region
  • 3.10.10. Annual median deal size by investor group
  • 3.10.11. Annual mega-round funding & deals
  • 3.10.12. Quarterly funding & deals from mega-rounds (deals worth usd 100 million+)
  • 3.10.13. Quarter mega-round funding & deals by global region
  • 3.10.14. Quarterly mega-round deals by global region
  • 3.10.15. Quarterly mega-rounds as percentage of funding
  • 3.10.16. Quarter top equity deals
  • 3.10.17. Annual percentage of deals by deal stage
  • 3.10.18. Quarter regional deal shares by deal stage
  • 3.10.19. Annual median funding by deal stage
  • 3.10.20. Quarter top seed/angel deals
  • 3.10.21. Quarter top series A deals
  • 3.10.22. Quarter top series B deals
  • 3.10.23. Quarter top series C deals
  • 3.10.24. Quarter top series D deals
  • 3.10.25. Quarter top series E+ deals
• 3.11. Unicorn Funding Trends in Digital Health
  • 3.11.1. Quarterly new & total unicorns (private companies valued at USD 1 billion+)
  • 3.11.2. Quarter new & total unicorns by global region
  • 3.11.3. Quarterly new unicorns by global region
  • 3.11.4. Quarter top unicorns by valuation
• 3.12. Exit Trends in Digital Health Market
  • 3.12.1. Annual exits
  • 3.12.2. Quarterly exits
  • 3.12.3. Percent of quarterly exits by global region
  • 3.12.4. Quarter top M&A exits
  • 3.12.5. Quarter top IPOs
• 3.13. Key Investors Analysis in the Digital Health Landscape
  • 3.13.1. Quarter top investors by company count
  • 3.13.2. Quarter top VCs by company count
  • 3.13.3. Quarter top corporate VCs (CVCs) by company count
• 3.14. Key Investment Geographic Trends in Digital Health Market
  • 3.14.1. U.S. Trends
    • 3.14.1.1. Annual funding & deals
    • 3.14.1.2. Quarterly funding & deals
    • 3.14.1.3. Annual percentage of deals by deal stage
    • 3.14.1.4. Quarter top equity deals
    • 3.14.1.5. Annual exits
    • 3.14.1.6. Quarterly exists
    • 3.14.1.7. Quarter top investors by company count
  • 3.14.2. Asia Trends
    • 3.14.2.1. Annual funding & deals
    • 3.14.2.2. Quarterly funding & deals
    • 3.14.2.3. Annual percentage of deals by deal stage
    • 3.14.2.4. Quarter top equity deals
    • 3.14.2.5. Annual exits
    • 3.14.2.6. Quarterly exists
    • 3.14.2.7. Quarter top investors by company count
  • 3.14.3. China
  • 3.14.4. Japan
  • 3.14.5. Europe Trends
    • 3.14.5.1. Annual funding & deals
    • 3.14.5.2. Quarterly funding & deals
    • 3.14.5.3. Annual percentage of deals by deal stage
    • 3.14.5.4. Quarter top equity deals
    • 3.14.5.5. Annual exits
    • 3.14.5.6. Quarterly exists
    • 3.14.5.7. Quarter top investors by company count
  • 3.14.6. UK

Chapter 4. Telecare Market Segment Analysis, By Type, 2018-2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Telecare Market, by Type, 2018 to 2030
• 4.5. Activity Monitoring
  • 4.5.1. Activity Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Remote Medication Management
  • 4.6.1. Remote Medication Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Telecare Market Segment Analysis, By Region, 2018- 2030 (USD Million)

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Regional Market Snapshot
• 5.4. Telecare Market Share by Region, 2024 & 2030:
• 5.5. North America
  • 5.5.1. North America telecare market, 2018 - 2030 (USD Million)
  • 5.5.2. U.S.
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Regulatory Scenario
    • 5.5.2.3. Competitive Scenario
    • 5.5.2.4. U.S. telecare market, 2018 - 2030 (USD Million)
  • 5.5.3. Canada
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Regulatory Scenario
    • 5.5.3.3. Competitive Scenario
    • 5.5.3.4. Canada telecare market, 2018 - 2030 (USD Million)
  • 5.5.4. Mexico
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Regulatory Scenario
    • 5.5.4.3. Competitive Scenario
    • 5.5.4.4. Mexico telecare market, 2018 - 2030 (USD Million)
• 5.6. Europe
  • 5.6.1. Europe telecare market, 2018 - 2030 (USD Million)
  • 5.6.2. UK
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Regulatory Scenario
    • 5.6.2.3. Competitive Scenario
    • 5.6.2.4. UK telecare market, 2018 - 2030 (USD Million)
  • 5.6.3. Germany
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Regulatory Scenario
    • 5.6.3.3. Competitive Scenario
    • 5.6.3.4. Germany telecare market, 2018 - 2030 (USD Million)
  • 5.6.4. France
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Regulatory Scenario
    • 5.6.4.3. Competitive Scenario
    • 5.6.4.4. France telecare market, 2018 - 2030 (USD Million)
  • 5.6.5. Italy
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Regulatory Scenario
    • 5.6.5.3. Competitive Scenario
    • 5.6.5.4. Italy telecare market, 2018 - 2030 (USD Million)
  • 5.6.6. Spain
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Regulatory Scenario
    • 5.6.6.3. Competitive Scenario
    • 5.6.6.4. Spain telecare market, 2018 - 2030 (USD Million)
  • 5.6.7. Norway
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Regulatory Scenario
    • 5.6.7.3. Competitive Scenario
    • 5.6.7.4. Norway telecare market, 2018 - 2030 (USD Million)
  • 5.6.8. Sweden
    • 5.6.8.1. Key Country Dynamics
    • 5.6.8.2. Regulatory Scenario
    • 5.6.8.3. Competitive Scenario
    • 5.6.8.4. Sweden telecare market, 2018 - 2030 (USD Million)
  • 5.6.9. Denmark
    • 5.6.9.1. Key Country Dynamics
    • 5.6.9.2. Regulatory Scenario
    • 5.6.9.3. Competitive Scenario
    • 5.6.9.4. Denmark telecare market, 2018 - 2030 (USD Million)
• 5.7. Asia Pacific
  • 5.7.1. Asia Pacific telecare market, 2018 - 2030 (USD Million)
  • 5.7.2. Japan
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Regulatory Scenario
    • 5.7.2.3. Competitive Scenario
    • 5.7.2.4. Japan telecare market, 2018 - 2030 (USD Million)
  • 5.7.3. China
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Regulatory Scenario
    • 5.7.3.3. Competitive Scenario
    • 5.7.3.4. China telecare market, 2018 - 2030 (USD Million)
  • 5.7.4. India
    • 5.7.4.1. Key Country Dynamics
    • 5.7.4.2. Regulatory Scenario
    • 5.7.4.3. Competitive Scenario
    • 5.7.4.4. India telecare market, 2018 - 2030 (USD Million)
  • 5.7.5. Australia
    • 5.7.5.1. Key Country Dynamics
    • 5.7.5.2. Regulatory Scenario
    • 5.7.5.3. Competitive Scenario
    • 5.7.5.4. Australia telecare market, 2018 - 2030 (USD Million)
  • 5.7.6. South Korea
    • 5.7.6.1. Key Country Dynamics
    • 5.7.6.2. Regulatory Scenario
    • 5.7.6.3. Competitive Scenario
    • 5.7.6.4. South Korea telecare market, 2018 - 2030 (USD Million)
  • 5.7.7. Thailand
    • 5.7.7.1. Key Country Dynamics
    • 5.7.7.2. Regulatory Scenario
    • 5.7.7.3. Competitive Scenario
    • 5.7.7.4. Thailand telecare market, 2018 - 2030 (USD Million)
• 5.8. Latin America
  • 5.8.1. Latin America telecare market, 2018 - 2030 (USD Million)
  • 5.8.2. Brazil
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Regulatory Scenario
    • 5.8.2.3. Competitive Scenario
    • 5.8.2.4. Brazil telecare market, 2018 - 2030 (USD Million)
  • 5.8.3. Argentina
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Regulatory Scenario
    • 5.8.3.3. Competitive Scenario
    • 5.8.3.4. Argentina telecare market, 2018 - 2030 (USD Million)
• 5.9. MEA
  • 5.9.1. MEA telecare market, 2018 - 2030 (USD Million)
  • 5.9.2. South Africa
    • 5.9.2.1. Key Country Dynamics
    • 5.9.2.2. Regulatory Scenario
    • 5.9.2.3. Competitive Scenario
    • 5.9.2.4. South Africa telecare market, 2018 - 2030 (USD Million)
  • 5.9.3. Saudi Arabia
    • 5.9.3.1. Key Country Dynamics
    • 5.9.3.2. Regulatory Scenario
    • 5.9.3.3. Competitive Scenario
    • 5.9.3.4. Saudi Arabia telecare market, 2018 - 2030 (USD Million)
  • 5.9.4. UAE
    • 5.9.4.1. Key Country Dynamics
    • 5.9.4.2. Regulatory Scenario
    • 5.9.4.3. Competitive Scenario
    • 5.9.4.4. UAE telecare market, 2018 - 2030 (USD Million)
  • 5.9.5. Kuwait
    • 5.9.5.1. Key Country Dynamics
    • 5.9.5.2. Regulatory Scenario
    • 5.9.5.3. Competitive Scenario
    • 5.9.5.4. Kuwait telecare market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company Categorization
• 6.3. Company Position Analysis
• 6.4. Company Evaluation Metrix
• 6.5. Company Profiles
  • 6.5.1. Teladoc Health, Inc.
    • 6.5.1.1. Company overview
    • 6.5.1.2. Financial performance
    • 6.5.1.3. Product benchmarking
    • 6.5.1.4. Strategic initiatives
  • 6.5.2. Abbott Laboratories
    • 6.5.2.1. Company overview
    • 6.5.2.2. Financial performance
    • 6.5.2.3. Product benchmarking
    • 6.5.2.4. Strategic initiatives
  • 6.5.3. Johnson and Johnson
    • 6.5.3.1. Company overview
    • 6.5.3.2. Financial performance
    • 6.5.3.3. Product benchmarking
    • 6.5.3.4. Strategic initiatives
  • 6.5.4. AstraZeneca PLC
    • 6.5.4.1. Company overview
    • 6.5.4.2. Financial performance
    • 6.5.4.3. Product benchmarking
    • 6.5.4.4. Strategic initiatives
  • 6.5.5. F. Hoffmann-La Roche Ltd.
    • 6.5.5.1. Company overview
    • 6.5.5.2. Financial performance
    • 6.5.5.3. Product benchmarking
    • 6.5.5.4. Strategic initiatives
  • 6.5.6. Novartis AG
    • 6.5.6.1. Company overview
    • 6.5.6.2. Financial performance
    • 6.5.6.3. Product benchmarking
    • 6.5.6.4. Strategic initiatives
  • 6.5.7. NeoRehab
    • 6.5.7.1. Company overview
    • 6.5.7.2. Financial performance
    • 6.5.7.3. Product benchmarking
    • 6.5.7.4. Strategic initiatives
  • 6.5.8. Bristol-Myers Squibb Company
    • 6.5.8.1. Company overview
    • 6.5.8.2. Financial performance
    • 6.5.8.3. Product benchmarking
    • 6.5.8.4. Strategic initiatives
  • 6.5.9. GlaxoSmithKline plc
    • 6.5.9.1. Company overview
    • 6.5.9.2. Financial performance
    • 6.5.9.3. Product benchmarking
    • 6.5.9.4. Strategic initiatives
  • 6.5.10. Merck and Co., Inc.
    • 6.5.10.1. Company overview
    • 6.5.10.2. Financial performance
    • 6.5.10.3. Product benchmarking
    • 6.5.10.4. Strategic initiatives
  • 6.5.11. Pfizer, Inc.
    • 6.5.11.1. Company overview
    • 6.5.11.2. Financial performance
    • 6.5.11.3. Product benchmarking
    • 6.5.11.4. Strategic initiatives
  • 6.5.12. Sanofi
    • 6.5.12.1. Company overview
    • 6.5.12.2. Financial performance
    • 6.5.12.3. Product benchmarking
    • 6.5.12.4. Strategic initiatives
  • 6.5.13. Samsung Electronics Co. Ltd
    • 6.5.13.1. Company overview
    • 6.5.13.2. Financial performance
    • 6.5.13.3. Product benchmarking
    • 6.5.13.4. Strategic initiatives
  • 6.5.14. Qualcomm Technologies, Inc.
    • 6.5.14.1. Company overview
    • 6.5.14.2. Financial performance
    • 6.5.14.3. Product benchmarking
    • 6.5.14.4. Strategic initiatives
  • 6.5.15. Orange
    • 6.5.15.1. Company overview
    • 6.5.15.2. Financial performance
    • 6.5.15.3. Product benchmarking
    • 6.5.15.4. Strategic initiatives
  • 6.5.16. Google (Alphabet), Inc
    • 6.5.16.1. Company overview
    • 6.5.16.2. Financial performance
    • 6.5.16.3. Product benchmarking
    • 6.5.16.4. Strategic initiatives
  • 6.5.17. Allscripts
    • 6.5.17.1. Company overview
    • 6.5.17.2. Financial performance
    • 6.5.17.3. Product benchmarking
    • 6.5.17.4. Strategic initiatives
  • 6.5.18. Apple, Inc.
    • 6.5.18.1. Company overview
    • 6.5.18.2. Financial performance
    • 6.5.18.3. Product benchmarking
    • 6.5.18.4. Strategic initiatives
  • 6.5.19. AT&T
    • 6.5.19.1. Company overview
    • 6.5.19.2. Financial performance
    • 6.5.19.3. Product benchmarking
    • 6.5.19.4. Strategic initiatives
  • 6.5.20. Airstrip Technologies, Inc
    • 6.5.20.1. Company overview
    • 6.5.20.2. Financial performance
    • 6.5.20.3. Product benchmarking
    • 6.5.20.4. Strategic initiatives

관련자료